BioWorld

June 21, 2001

View Archived Issues

Other News To Note

Read More

U.S. Patent Disclosures

Read More

AtheroGenics Completes $20M Private Placement To Fund Trials

Read More

Inspire Reacquires Rights To P2Y2 Agonists From Genentech

Read More

Corcept Emerges, Raises $27M To Fund C-1073 Phase III Trials

Read More

Flooding Angiogenic Molecule Into Tumor Patients May Cause Dire, But Reversible, Defect

Read More

House Subcommittee Hears Testimony On Cloning Bills

Read More